Biorad Medisys Pvt Ltd

Belkins
Biorad Medisys is a leading global specialty manufacturer of a large portfolio of implants and surgical devices . Full-fledged integrated manufacturing facilities in Pune and Bengaluru, adhering to strict GMP are set up, starting its operations almost a decade ago the company operates under stringent guidelines and certified by ISO 13485/IS0 9001-2008. The facilities boast of state of the art machinery imported from UK, Germany & Japan. The company develops and markets innovative technologies and medical products through its two divisions; Orthovasive and Indovasive which are CE certified and partners with healthcare professionals in enhancing patient care.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMA TECH

PFIZER, BIONTECH COVID-19 VACCINE WORKS IN MORE CONTAGIOUS CORONAVIRUS VARIANTS

Pfizer | January 11, 2021

news image

Newly emerged variants of the novel coronavirus have sparked a key question: Will existing COVID-19 vaccines be less effective against them? But scientists have preliminary data showing that may not be the case, at least for Pfizer and BioNTech’s shot. Researchers from the University of Texas and Pfizer found that, in lab dishes, the vaccine was able to neutralize an engineered version of a variant, which bears an N501Y mutation in its spike protein. The finding was publishe...

Read More

PHARMA TECH

CAPACITY AND CITELINE CONNECT PARTNER FOR AI-POWERED CLINICAL TRIAL RECRUITMENT EXPERIENCE

Capacity | August 12, 2021

news image

Capacity, an AI-powered support automation platform, today announces its partnership with Citeline Connect, the all-in-one clinical trial recruitment platform developed by Informa Pharma Intelligence. The companies partnered to launch Moderna's clinical trial recruitment website with an AI-powered chatbot to provide a comprehensive experience for potential study participants. This partnership enables customers like Moderna to create engaging clinical trial recruitment websites...

Read More

CSA MEDICAL ANNOUNCES FIRST PROCEDURE IN THE SPRAY-CB PIVOTAL TRIAL FOR THE TREATMENT OF CHRONIC BRONCHITIS

CSA Medical Inc | October 22, 2020

news image

CSA Medical Inc., a developer of medical devices advancing the power of liquid nitrogen spray cryotherapy, today announced the first patient treated in the SPRAY-CB, U.S. pivotal trial utilizing the RejuvenAir® System for COPD with Chronic Bronchitis at Temple University. Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University (LKSOM) and Director of the Temple Lung Center, and principal investigator co...

Read More

SEVEN PHARMACEUTICAL STOCKS THAT STAND TO WIN BEYOND THE COVID-19 CHASE

InvestorPlace | July 15, 2020

news image

It’s easy to miss the forest for the trees in markets like this. Especially when it comes to pharmaceutical stocks. What I mean is that, in some sectors, there are great stocks that get overlooked because a few of them are working on event-driven issues, while others are creating long-term solutions to major trends. This is especially true in the pharmaceutical and biotech spaces right now. Maybe it’s because the Kentucky Derby was postponed, but people are betting on ...

Read More

PHARMA TECH

Pfizer | January 11, 2021

news image

PFIZER, BIONTECH COVID-19 VACCINE WORKS IN MORE CONTAGIOUS CORONAVIRUS VARIANTS

Newly emerged variants of the novel coronavirus have sparked a key question: Will existing COVID-19 vaccines be less effective against them? But scientists have preliminary data showing that may not be the case, at least for Pfizer and BioNTech’s shot. Researchers from the University of Texas and Pfizer found that, in lab dishes, the vaccine was able to neutralize an engineered version of a variant, which bears an N501Y mutation in its spike protein. The finding was publishe...

Read More

PHARMA TECH

Capacity | August 12, 2021

news image

CAPACITY AND CITELINE CONNECT PARTNER FOR AI-POWERED CLINICAL TRIAL RECRUITMENT EXPERIENCE

Capacity, an AI-powered support automation platform, today announces its partnership with Citeline Connect, the all-in-one clinical trial recruitment platform developed by Informa Pharma Intelligence. The companies partnered to launch Moderna's clinical trial recruitment website with an AI-powered chatbot to provide a comprehensive experience for potential study participants. This partnership enables customers like Moderna to create engaging clinical trial recruitment websites...

Read More

CSA Medical Inc | October 22, 2020

news image

CSA MEDICAL ANNOUNCES FIRST PROCEDURE IN THE SPRAY-CB PIVOTAL TRIAL FOR THE TREATMENT OF CHRONIC BRONCHITIS

CSA Medical Inc., a developer of medical devices advancing the power of liquid nitrogen spray cryotherapy, today announced the first patient treated in the SPRAY-CB, U.S. pivotal trial utilizing the RejuvenAir® System for COPD with Chronic Bronchitis at Temple University. Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University (LKSOM) and Director of the Temple Lung Center, and principal investigator co...

Read More

InvestorPlace | July 15, 2020

news image

SEVEN PHARMACEUTICAL STOCKS THAT STAND TO WIN BEYOND THE COVID-19 CHASE

It’s easy to miss the forest for the trees in markets like this. Especially when it comes to pharmaceutical stocks. What I mean is that, in some sectors, there are great stocks that get overlooked because a few of them are working on event-driven issues, while others are creating long-term solutions to major trends. This is especially true in the pharmaceutical and biotech spaces right now. Maybe it’s because the Kentucky Derby was postponed, but people are betting on ...

Read More